
Home » Active Biotech AB Releases Results From Phase II/III ANYARA Trial for the Treatment of Renal Cell Cancer
Active Biotech AB Releases Results From Phase II/III ANYARA Trial for the Treatment of Renal Cell Cancer
Active Biotech announced the initial results from the ANYARA Phase II/III clinical study.
4-Traders
4-Traders
Upcoming Events
-
10Aug
-
08Sep
-
15Sep
-
20Sep
-
21Sep
-
22Sep